Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 59Pancreatic Neoplasms 32Colonic Neoplasms 31Rectal Neoplasms 30Stomach Neoplasms 22Neoplasm Metastasis 19Carcinoma, Non-Small-Cell Lung 19Neoplasms 16Unspecified Adult Solid Tumor, Protocol Specific 15Esophageal Neoplasms 12Ovarian Neoplasms 8Gallbladder Neoplasms 7Appendiceal Neoplasms 7Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Lung Neoplasms 6Carcinoma, Renal Cell 6Breast Neoplasms 6Bile Duct Neoplasms 6Peritoneal Neoplasms 5Liver Neoplasms 5Gastrointestinal Neoplasms 5Carcinoma, Hepatocellular 5Adenocarcinoma 5Triple Negative Breast Neoplasms 4Recurrence 4Fallopian Tube Neoplasms 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Pancreatic Ductal 4Squamous Cell Carcinoma of Head and Neck 3

Interventions

Irinotecan 3Theophylline 1Temozolomide 1Oxaliplatin 1Loperamide 1Leucovorin 1Fluorouracil 1Fecal Microbiota Transplantation 1Erlotinib Hydrochloride 1Celecoxib 1Cefpodoxime 1Cefixime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diarrhea × Oxaliplatin × Clear all
NCT01164215 2015-10-09

Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
76 enrolled
Gastrointestinal

Colonic Neoplasms, Diarrhea, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡